[Deep sclerectomy for the management of uveitic glaucoma].

Abstract

PURPOSE:

To report middle-term results of deep sclerectomy in uveitis patients with glaucoma who are resistant to medical therapy.

PATIENTS AND METHODS:

Eight eyes of eight patients (mean age, 56.9 years; range, 46-67 years) with uveitic glaucoma resistant to medical therapy underwent deep sclerectomy without antimetabolites between 1994 and 2001. All patients had their uveitis controlled before and after surgery by anti-inflammatory therapy.

RESULTS:

Mean follow-up was 42.2 months. Intraocular pressure was reduced from a mean preoperative value of 32.3 mmHg to a mean postoperative value of 15.2 (52.9% reduction). Success was obtained in seven eyes (87.5%). It was complete in four eyes (57.2%) and relative in three eyes (42.8%). Failure was noted in one eye (12.5%), controlled later by trabeculectomy. Antiglaucomatous medication was reduced from a mean of 2.9 medications preoperatively to 0.6 medications (79.3% reduction). Postoperative complications included one case of lens opacity and one case of hyphema.

CONCLUSION:

The low rate of surgical complications and the lack of failure risk factors except inflammation and long-term use of antiglaucomatous medication may explain the high success rate of deep sclerectomy in this study.

• Authors: K Souissi, M A El Afrit, S Trojet, A Kraiem
• Journal: Journal francais d'ophtalmologie (J Fr Ophtalmol) Vol. 29 Issue 3 Pg. 265-8 (Mar 2006) ISSN: 1773-0597 [Electronic] France
• Vernacular Title: Sclérectomie profonde non perforante dans le traitement du glaucome uvéitique.
• PMID: 16557170 (Publication Type: English Abstract, Journal Article)

Topics

• Aged
• Female
• Glaucoma (etiology, surgery)
• Humans
• Male
• Middle Aged
• Retrospective Studies
• Sclera (surgery)
• Trabeculectomy
• Uveitis (complications, surgery)